The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study
1998

Study of Ifosfamide Administration Methods

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): JM Singer, JM Hartley, C Brennan, PW Nicholson, RL Souhami

Primary Institution: Department of Oncology, University College, London, UK

Hypothesis

Does the method of administration (bolus vs continuous infusion) affect the pharmacokinetics and metabolism of ifosfamide?

Conclusion

The study found no significant differences in the pharmacokinetics of ifosfamide between bolus and continuous infusion methods.

Supporting Evidence

  • The study involved 34 patient cycles and measured serum and urinary levels of ifosfamide and its metabolites.
  • Results showed no significant differences in pharmacokinetics between bolus and infusion methods.
  • Dexamethasone did not significantly affect ifosfamide metabolism.
  • Variability in drug handling was observed among patients.

Takeaway

Doctors wanted to see if giving a cancer drug called ifosfamide in two different ways would change how the body processes it, but they found it didn't make a difference.

Methodology

A randomized cross-over trial where 11 patients received ifosfamide in two different administration methods over multiple cycles.

Potential Biases

Potential variability in drug metabolism among patients could introduce bias.

Limitations

The study had a small sample size and variability in patient responses.

Participant Demographics

Patients aged 23-71 years, including four men and seven women.

Statistical Information

P-Value

0.002

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication